Pharmacokinetic boosting of olaparib: An open-label, prospective, cross-over study

被引：0
|
作者：
Overbeek, J. [1 ]
Guchelaar, N. [2 ]
Ali, M. I. Mohmaed [3 ,4 ]
Ottevanger, P. B.
Bloemendal, H. [5 ]
Koolen, S. [2 ]
Mathijssen, R. [2 ]
Boere, I. [6 ]
Hamberg, P. [6 ,7 ]
Huitema, A. [3 ,4 ]
Sonke, G. [8 ,9 ]
Opdam, F. [8 ,9 ]
Ter Heine, R. [1 ]
Van Erp, N. [1 ]
机构：
[1] Radboud Univ Nijmegen, Pharm, Med Ctr, Nijmegen, Netherlands
[2] Erasmus MC Canc Inst, Dept Med Oncol, Rotterdam, Netherlands
[3] Netherlands Canc Inst, Dept Pharm & Pharmacol, Amsterdam, Netherlands
[4] Antoni Leeuwenhoek, Amsterdam, Netherlands
[5] Radboud Univ Nijmegen, Med Oncol Dept, Med Ctr, Nijmegen, Netherlands
[6] Erasmus Univ, Dept Med Oncol, Med Ctr, Rotterdam, Netherlands
[7] Franciscus Gasthuis & Vlietland, Med Oncol, Schiedam, Netherlands
[8] NKI Netherlands Canc Inst, Dept Med Oncol, Amsterdam, Netherlands
[9] AVL Antoni Leeu wenhoek Hosp, Amsterdam, Netherlands
来源：
ANNALS OF ONCOLOGY | 2023年 / 34卷
关键词：
D O I：
10.1016/j.annonc.2023.09.1948
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
769P
引用
收藏
页码：S522 / S522
页数：1
相关论文
共 50 条
  • [31] Effect of hypoglycaemia on measures of myocardial blood flow and myocardial injury in adults with and without type 1 diabetes: A prospective, randomised, open-label, blinded endpoint, cross-over study
    Noh, Radzi M.
    Graveling, Alex J.
    Lang, Ninian N.
    White, Audrey C.
    Lee, Kuan K.
    Mills, Nicholas L.
    Newby, David E.
    Lang, Chim C.
    Frier, Brian M.
    ENDOCRINOLOGY DIABETES & METABOLISM, 2021, 4 (03)
  • [32] Pharmacokinetic Study of Intranasal Dexamethasone and Methylprednisolone Compared with Intravenous Administration: Two Open-Label, Single-Dose, Two-Period, Two-Sequence, Cross-Over Study in Healthy Volunteers
    Cardenas, Graciela
    Bobes, Raul J.
    Fragoso, Gladis
    Perez-Osorio, Nicolas I.
    Hernandez, Marisela
    Espinosa, Alejandro
    Fleury, Agnes
    Flores, Jose
    Laclette, Juan Pedro
    Sciutto, Edda
    Jung-Cook, Helgi
    PHARMACEUTICS, 2023, 15 (01)
  • [33] Efficacy of amitriptyline and duloxetine in post-chikungunya neuropathic pain; a randomized, open-label, cross-over clinical trial
    Kamal, Md Mostafa
    Rahman, Md Mizanur
    Sharmin, Shahrina
    Bhowmick, Dilip Kumar
    Islam, Md Shafiqul
    Akhtaruzzaman, A. K. M.
    ANAESTHESIA PAIN & INTENSIVE CARE, 2021, 25 (05) : 647 - 652
  • [34] Evaluation of the Keeogo exoskeleton for assisting ambulatory activities in people with multiple sclerosis: an open-label, randomized, cross-over trial
    Chris A. McGibbon
    Andrew Sexton
    Arun Jayaraman
    Susan Deems-Dluhy
    Pearl Gryfe
    Alison Novak
    Tilak Dutta
    Eric Fabara
    Catherine Adans-Dester
    Paolo Bonato
    Journal of NeuroEngineering and Rehabilitation, 15
  • [35] Evaluation of the Keeogo exoskeleton for assisting ambulatory activities in people with multiple sclerosis: an open-label, randomized, cross-over trial
    McGibbon, Chris A.
    Sexton, Andrew
    Jayaraman, Arun
    Deems-Dluhy, Susan
    Gryfe, Pearl
    Novak, Alison
    Dutta, Tilak
    Fabara, Eric
    Adans-Dester, Catherine
    Bonato, Paolo
    JOURNAL OF NEUROENGINEERING AND REHABILITATION, 2018, 15
  • [36] Efficacy and safety of pemafibrate versus bezafibrate in coronary artery disease patients receiving statin treatment: a randomized, open-label, cross-over study
    Nakamura, A.
    Kagaya, Y.
    Saito, H.
    Kanazawa, M.
    Sato, K.
    Miura, M.
    Kondo, M.
    Endo, H.
    EUROPEAN HEART JOURNAL, 2022, 43 : 2665 - 2665
  • [37] Validating a composite endpoint for acceptability evaluation of oral drug formulations in the pediatric population: a randomized, open-label, single dose, cross-over study
    Muench, Juliane
    Schwarzwaelder, Anna Lena
    Kloft, Carolin
    Bosse, Hans Martin
    Wargenau, Manfred
    Reidemeister, Sibylle
    Klingmann, Ingrid
    Klingmann, Viviane
    FRONTIERS IN PHARMACOLOGY, 2024, 15
  • [38] Ritonavir-Boosted Exposure of Kinase Inhibitors: an Open Label, Cross-over Pharmacokinetic Proof-of-Concept Trial with Erlotinib
    Boosman, Rene J.
    de Gooijer, Cornedine J.
    Groenland, Stefanie L.
    Burgers, Jacobus A.
    Baas, Paul
    van der Noort, Vincent
    Beijnen, Jos H.
    Huitema, Alwin D. R.
    Steeghs, Neeltje
    PHARMACEUTICAL RESEARCH, 2022, 39 (04) : 669 - 676
  • [39] Ritonavir-Boosted Exposure of Kinase Inhibitors: an Open Label, Cross-over Pharmacokinetic Proof-of-Concept Trial with Erlotinib
    René J. Boosman
    Cornedine J. de Gooijer
    Stefanie L. Groenland
    Jacobus A. Burgers
    Paul Baas
    Vincent van der Noort
    Jos H. Beijnen
    Alwin D.R. Huitema
    Neeltje Steeghs
    Pharmaceutical Research, 2022, 39 : 669 - 676
  • [40] Baricitinib for the treatment of cutaneous dermatomyositis: A prospective, open-label study
    Zhao, Qian
    Zhu, Zicong
    Fu, Qiaoyu
    Shih, Yanting
    Wu, Dan
    Chen, Lihong
    Zheng, Jie
    Cao, Hua
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2022, 87 (06) : 1374 - 1376
12345